Surgical Adhesion Barriers are bands of scar-like tissue that form abnormal fibrous connections joining tissue surfaces in abnormal locations. In general, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of serosal surface to firm agglutination of nearly all structures. However, post-surgical adhesion has a considerable epidemiological and clinical impact mostly due to tissue damage caused by surgical traumas.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Surgical Adhesion Barriers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Surgical Adhesion Barriers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Surgical Adhesion Barriers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Actamax Surgical Materials LLC
- Alafair Biosciences Inc
- Anika Therapeutics Inc
- ARC Medical Devices Inc
- ARC Medical Inc.
- Baxter International Inc
- BioActive Polymers in Lund AB
- Dalim Tissen Co Ltd
- Duke University
- FzioMed Inc
- Genzyme Corp
- HydroGlaze BV
- Innocoll Technologies Ltd (Inactive)
- Jinwoo Bio Co Ltd
- Kytogenics Pharmaceuticals Inc
- Leader Biomedical Europe BV
- Luna Innovations Inc
- Magen OrthoMed Ltd
- Maxigen Biotech Inc
- Medisse BV (Inactive)
- MLM Biologics Inc
- PolyNovo Biomaterials Pty Ltd
- Rutgers The State University of New Jersey
- Seikagaku Corp
- Sporogenics Pte Ltd
- Stony Brook University
- Toray Medical Co Ltd
- Tribos LLC
- TYBR Health Inc
- University of North Carolina at Chapel Hill

